Maten som kan skydda dig mot demens | Hjärnfonden
Genes | Free Full-Text | Advances in Genetic and Molecular Understanding of Alzheimer's Disease
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options - IOS Press
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease - Xu - CNS Neuroscience & Therapeutics - Wiley Online Library
A metabolic perspective of late onset Alzheimer's disease - ScienceDirect
IJMS | Free Full-Text | Natural Products Targeting Amyloid Beta in Alzheimer's Disease
Old School Gospel Concert Fundraiser Benefitting the Kosten Foundation and Pancreatic Cancer Research - Herb Kosten Foundation
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease | NEJM
Alzheimer's disease and its treatment by different approaches: A review - ScienceDirect
Frontiers | Mouse Models of Alzheimer's Disease
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease - ScienceDirect
Current and emerging avenues for Alzheimer's disease drug targets - Loera‐Valencia - 2019 - Journal of Internal Medicine - Wiley Online Library
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial -
Ketogen kost för att förebygga och behandla Alzheimers - Diet Doctor
Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease | Hypertension
Frontiers | The Role of P2X7 Receptor in Alzheimer's Disease
Advances in Modeling Alzheimer's Disease In Vitro - Sharma - 2021 - Advanced NanoBiomed Research - Wiley Online Library
Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR) - ScienceDirect
Frontiers | Insulin Resistance in Alzheimer's Disease
IJMS | Free Full-Text | Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease
Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies - ScienceDirect
Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers - Nørgaard - 2022 - Alzheimer's & Dementia: Translational
